Skip to content

KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) Calculator

Healing & RecoveryInjectionResearchVaries by component half-life

Calculate exact syringe units for the KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) pre-mixed blend. The dose shown is from the combined vial. No separate math needed.

Calculate your dose

Adjust vial, water and dose. The answer updates live.

mL
Dose
Syringe

All three take the same units for the same dose. A smaller barrel just spreads it over more space.

↓ 7.5020406080100
Draw to 7.5 units= 0.075 mL

on a U-100 syringe for a 2,000 mcg = 2 mg dose

Check that your syringe says U-100.

What this draw delivers
GHK-Cu 1,250 mcgBPC-157 250 mcgTB-500 250 mcgKPV 250 mcg

Assumes the pre-blended 80 mg vial, 5:1:1:1 GHK-Cu : BPC-157 : TB-500 : KPV.

Concentration
26,666.667
mcg/mL
Doses / vial
40
Cost / dose
$1.63–9.50
Range
Your mixing recipe

Add 3 mL BAC water to your 80 mg vial. Draw to 7.5 units on a U-100 syringe for a 2 mg dose. This vial will last 40 doses.

A reminder for 2 mg (7.5 units) every day, with a free account.

Dose math and a schedule you can keep.

Syringe units in one tap. A free account adds dose reminders and calendar sync, plus alerts on the peptides you save.

Track every dose with reminders and a calendar.

  • Dose remindersPush or calendar alarm
  • Peptide alertsFor peptides you save
  • Calendar syncApple, Google, Outlook
  • Supply countsDoses left per vial

Your plans, logs and saved peptides sync to every device.

Opens a preview of your schedule first.

Your logs and saved lists are never sold, and not shared except where you choose.

What's in This Blend

About This Blend

Does stacking four preclinical peptides in one vial actually make sense? The KLOW Blend (also called the KLOW Protocol) puts GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg) together in a fixed 5:1:1:1 ratio. It evolved from the three-peptide GLOW stack. The addition of KPV brought anti-inflammatory gut protection into the mix.

Each component works through a separate mechanism. GHK-Cu is a copper-binding tripeptide first isolated by Loren Pickart in 1973. His group's analysis of public gene data from human cell lines found it shifts the activity of at least 4,000 genes (PMID 26236730). In skin cell cultures it increased collagen and elastin production (PMID 29986520). BPC-157 is a 15-amino-acid gastric juice fragment. Predrag Sikiric's group in Zagreb appears on 175 of its 233 PubMed records (October 2026), including a rat study of faster intestinal anastomosis healing (PMID 17713731). A Taiwanese lab tied its tendon effect to FAK-paxillin signaling in rat tendon fibroblasts (PMID 21030672). TB-500, a synthetic fragment of thymosin beta-4, promotes actin polymerization and cell migration. Goldstein's original work showed it increased keratinocyte migration 2- to 3-fold at concentrations as low as 10pg (PMID 10469335). KPV enters intestinal epithelial cells via the PepT1 transporter and suppresses NF-kB inflammatory signaling at nanomolar concentrations (Dalmasso et al., PMID 18061177).

The typical community protocol runs 2000mcg total blend per day for 10 weeks, followed by 4 weeks off. Most of the interest comes from the GLP-1 companion use case. Users on semaglutide or tirzepatide report that KLOW reduces nausea and supports skin tightening during rapid weight loss. That framing is entirely anecdotal. No clinical endpoint data supports it.

The FDA classified BPC-157 and GHK-Cu as Category 2 bulk drug substances in 2023-2024, restricting compounding pharmacy access. Both BPC-157 and TB-500 are WADA-prohibited. Research-grade prices run $65 to $380 per vial, with most landing near $100 to $135.

KLOW Blend benefits center on tissue recovery, gut protection, and body recomposition support during aggressive fat loss phases.
Reduces systemic inflammation through NF-kB pathway suppression. KPV enters intestinal epithelial cells via PepT1 and blocks pro-inflammatory cytokine production at nanomolar concentrations (Dalmasso et al., PMID 18061177).
Supports gut mucosal healing in rats; use during GLP-1 therapy rests on user reports. BPC-157's gut protective effects come mostly from rat studies by Sikiric's Zagreb group (PMID 17713731, PMID 21548867). Users on semaglutide and tirzepatide consistently report reduced nausea and bloating when adding KLOW.
Supports skin elasticity and collagen production during rapid weight loss. GHK-Cu upregulates collagen I, collagen III, and elastin genes (Pickart, PMID 29986520). Community reports describe visible skin tightening by weeks 5 to 7 of a cycle.
Promotes tendon and ligament repair. BPC-157 drives tendon outgrowth through FAK-paxillin signaling (PMID 21030672); TB-500 promotes cell migration via actin polymerization (PMID 10469335). Together they cover two separate tissue repair mechanisms.
Preserves connective tissue integrity during caloric restriction. Users running 500+ calorie deficits report less joint stiffness and fewer soft tissue complaints when cycling KLOW at beginner dose.
Offers single-vial convenience over sourcing four separate peptides. One reconstitution, one daily injection, four active components.
View full blend guide →
Print the KLOW Blend protocol card (free PDF)

One page: what is in the vial, the dose each tier delivers per component, syringe units, cycling, and where every number comes from.

Frequently Asked Questions

It depends which product you have. This calculator covers the pre-blended 80 mg vial (5:1:1:1 GHK-Cu : BPC-157 : TB-500 : KPV). Enter your vial size (80mg) and BAC water amount above, and the dose shown is the total drawn from that combined vial. The ratio is fixed when the vial is made, so the split between components follows from the total and you cannot move one without moving the others. Blend ratios are not standardized across products. Confirm the milligram breakdown on your COA before dosing. If your ratio differs, the component split above does not apply.

The pre-blended 80 mg vial holds 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500, 10mg KPV, a 5:1:1:1 GHK-Cu : BPC-157 : TB-500 : KPV split. Each component targets a different pathway. Blend ratios are not standardized across products. Confirm the milligram breakdown on your COA before dosing. If your ratio differs, the component split above does not apply.

The standard is 3mL of bacteriostatic water. You can adjust this in the calculator to find a concentration that works for your syringe and dose.

Not medical advice. Talk to your provider before using any peptide. Full disclaimer